MOHIT KHERA

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Urology
Address7200 CAMBRIDGE
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Morgentaler A, Traish A, Barua RS, Dandona P, Dhindsa S, Khera M, Saad F. Recognizing the True Value of Testosterone Therapy in Health Care. Androg Clin Res Ther. 2022; 3(1):217-223. PMID: 36643964; PMCID: PMC9814113.
      Citations:    
    2. Patel SR, Reddy A, Dai M, Passoni N, Khera M, Koh CJ, Patel SR, Reddy A, Dai M, Passoni N, Khera M, Koh CJ. Is urgent surgical management necessary for priapism in pediatric patients with hematologic conditions? J Pediatr Urol. 2022 Aug; 18(4):528.e1-528.e6. PMID: 35843787.
      Citations:    Fields:    
    3. Khoei A, Racik N, Bansal U, Flores F, Khera M, Khoei A, Racik N, Bansal U, Flores F, Khera M. The Low Submuscular Reservoir Placement With Transfascial Fixation for Inflatable Penile Prostheses. J Sex Med. 2022 08; 19(8):1309-1312. PMID: 35718740.
      Citations:    Fields:    Translation:Humans
    4. Lopez DS, Kim H, Polychronopoulou E, Taha S, Tsilidis KK, Villasante-Tezanos A, Peek MK, Gilani S, Khera M, Baillargeon J, Kuo YF, Canfield S, Lopez DS, Kim H, Polychronopoulou E, Taha S, Tsilidis KK, Villasante-Tezanos A, Peek MK, Gilani S, Khera M, Baillargeon J, Kuo YF, Canfield S. Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015. Cancer Epidemiol. 2022 08; 79:102172. PMID: 35523034; PMCID: PMC9288979.
      Citations:    Fields:    Translation:Humans
    5. Miller LE, Khera M, Bhattacharyya S, Patel M, Nitschelm K, Burnett AL, Miller LE, Khera M, Bhattacharyya S, Patel M, Nitschelm K, Burnett AL. Long-Term Survival Rates of Inflatable Penile Prostheses: Systematic Review and Meta-Analysis. Urology. 2022 08; 166:6-10. PMID: 35421510.
      Citations:    Fields:    
    6. DelConte A, Papangkorn K, Kim K, Bruno BJ, Chidambaram N, Khera M, Goldstein I, Kohler TS, Miner M, Dobs AS, Patel MV, DelConte A, Papangkorn K, Kim K, Bruno BJ, Chidambaram N, Khera M, Goldstein I, Kohler TS, Miner M, Dobs AS, Patel MV. A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism. Andrology. 2022 05; 10(4):669-676. PMID: 34994093; PMCID: PMC9304136.
      Citations: 1     Fields:    Translation:Humans
    7. Auerbach JM, Khera M, Auerbach JM, Khera M. Testosterone replacement therapy and cardiovascular disease. Int J Impot Res. 2022 Nov; 34(7):685-690. PMID: 34999717.
      Citations:    Fields:    
    8. Pedraza AM, Pandav K, Menon M, Khera M, Wagaskar V, Dovey Z, Mohamed N, Parekh S, Tewari AK, Pedraza AM, Pandav K, Menon M, Khera M, Wagaskar V, Dovey Z, Mohamed N, Parekh S, Tewari AK. Current strategies to improve erectile function in patients undergoing radical prostatectomy - preoperative scenario. Urol Oncol. 2022 03; 40(3):72-78. PMID: 35012821.
      Citations:    Fields:    Translation:Humans
    9. Pedraza AM, Pandav K, Menon M, Khera M, Wagaskar V, Dovey Z, Mohamed N, Parekh S, Tewari AK, Pedraza AM, Pandav K, Menon M, Khera M, Wagaskar V, Dovey Z, Mohamed N, Parekh S, Tewari AK. Current strategies to improve erectile function in patients undergoing radical prostatectomy - postoperative scenario. Urol Oncol. 2022 03; 40(3):87-94. PMID: 35012822.
      Citations:    Fields:    Translation:Humans
    10. Pedraza AM, Pandav K, Menon M, Khera M, Wagaskar V, Dovey Z, Mohamed N, Parekh S, Tewari AK, Pedraza AM, Pandav K, Menon M, Khera M, Wagaskar V, Dovey Z, Mohamed N, Parekh S, Tewari AK. Current strategies to improve erectile function in patients undergoing radical prostatectomy-intraoperative scenario. Urol Oncol. 2022 03; 40(3):79-86. PMID: 35012823.
      Citations:    Fields:    Translation:Humans
    11. Reddy AG, Khoei AA, Khera M, Reddy AG, Khoei AA, Khera M. The Potential for Pharmacological Interventions for Low Sex Drive in Men. J Sex Med. 2022 02; 19(2):165-169. PMID: 34991979.
      Citations:    Fields:    Translation:Humans
    12. Healy D, Bahrick A, Bak M, Barbato A, Calabrò RS, Chubak BM, Cosci F, Csoka AB, D'Avanzo B, Diviccaro S, Giatti S, Goldstein I, Graf H, Hellstrom WJG, Irwig MS, Jannini EA, Janssen PKC, Khera M, Kumar MT, Le Noury J, Lew-Starowicz M, Linden DEJ, Lüning C, Mangin D, Melcangi RC, Rodríguez OWMAAS, Panicker JN, Patacchini A, Pearlman AM, Pukall CF, Raj S, Reisman Y, Rubin RS, Schreiber R, Shipko S, Vašecková B, Waraich A, Healy D, Bahrick A, Bak M, Barbato A, Calabrò RS, Chubak BM, Cosci F, Csoka AB, D'Avanzo B, Diviccaro S, Giatti S, Goldstein I, Graf H, Hellstrom WJG, Irwig MS, Jannini EA, Janssen PKC, Khera M, Kumar MT, Le Noury J, Lew-Starowicz M, Linden DEJ, Lüning C, Mangin D, Melcangi RC, Rodríguez OWMAAS, Panicker JN, Patacchini A, Pearlman AM, Pukall CF, Raj S, Reisman Y, Rubin RS, Schreiber R, Shipko S, Vašecková B, Waraich A. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int J Risk Saf Med. 2022; 33(1):65-76. PMID: 34719438; PMCID: PMC8925105.
      Citations: 2     Fields:    Translation:Humans
    13. Bhasin S, Lincoff AM, Basaria S, Bauer DC, Boden WE, Cunningham GR, Davey D, Dubcenco E, Fukumoto S, Garcia M, Granger CB, Kalahasti V, Khera M, Miller MG, Mitchell LM, O'Leary MP, Pencina KM, Snyder PJ, Thompson IM, Travison TG, Wolski K, Nissen SE, Bhasin S, Lincoff AM, Basaria S, Bauer DC, Boden WE, Cunningham GR, Davey D, Dubcenco E, Fukumoto S, Garcia M, Granger CB, Kalahasti V, Khera M, Miller MG, Mitchell LM, O'Leary MP, Pencina KM, Snyder PJ, Thompson IM, Travison TG, Wolski K, Nissen SE, TRAVERSE Study Investigators. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. Am Heart J. 2022 03; 245:41-50. PMID: 34871580.
      Citations: 3     Fields:    Translation:Humans
    14. Bansal UK, Lopez JP, Flores-Sandoval FN, Khera M, Bansal UK, Lopez JP, Flores-Sandoval FN, Khera M. Ectopic low submuscular pressure regulating balloon placement with transfascial fixation for artificial urinary sphincter. Can J Urol. 2021 12; 28(6):10936-10940. PMID: 34895399.
      Citations:    Fields:    Translation:Humans
    15. El-Khatib FM, Huynh LM, Kopelevich A, Osman MM, Choi E, Nguyen JT, Dianatnejad S, Wu Q, Olivas MG, Spitz A, Lowry J, Losso BY, Khera M, Angulo-Llanos L, Patel P, Ramasamy R, Yafi FA, El-Khatib FM, Huynh LM, Kopelevich A, Osman MM, Choi E, Nguyen JT, Dianatnejad S, Wu Q, Olivas MG, Spitz A, Lowry J, Losso BY, Khera M, Angulo-Llanos L, Patel P, Ramasamy R, Yafi FA. Comparative assessment of outcomes and adverse effects using two different intramuscular testosterone therapy regimens: 100?mg IM weekly or 200?mg IM biweekly. Int J Impot Res. 2022 Sep; 34(6):558-563. PMID: 34257404.
      Citations:    Fields:    
    16. Howell S, Song W, Pastuszak A, Khera M, Howell S, Song W, Pastuszak A, Khera M. Differential Gene Expression in Post-Finasteride Syndrome Patients. J Sex Med. 2021 09; 18(9):1479-1490. PMID: 34247957.
      Citations:    Fields:    Translation:Humans
    17. White WB, Dobs A, Carson C, DelConte A, Khera M, Miner M, Shahid M, Kim K, Chidambaram N, White WB, Dobs A, Carson C, DelConte A, Khera M, Miner M, Shahid M, Kim K, Chidambaram N. Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men. J Cardiovasc Pharmacol Ther. 2021 11; 26(6):630-637. PMID: 34191621.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    18. Lopez DS, Huang D, Tsilidis KK, Canfield S, Khera M, Baillargeon JG, Kuo YF, Peek MK, Platz EA, Markides K, Lopez DS, Huang D, Tsilidis KK, Canfield S, Khera M, Baillargeon JG, Kuo YF, Peek MK, Platz EA, Markides K. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer. Cancer Causes Control. 2021 Sep; 32(9):965-976. PMID: 34041642; PMCID: PMC8316375.
      Citations: 1     Fields:    Translation:Humans
    19. Grober ED, Krakowsky Y, Khera M, Holmes DT, Lee JC, Grantmyre JE, Patel P, Bebb RA, Fitzpatrick R, Campbell JD, Carrier S, Morgentaler A, Grober ED, Krakowsky Y, Khera M, Holmes DT, Lee JC, Grantmyre JE, Patel P, Bebb RA, Fitzpatrick R, Campbell JD, Carrier S, Morgentaler A. Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A. Can Urol Assoc J. 2021 May; 15(5):E234-E243. PMID: 33661092; PMCID: PMC8095276.
      Citations: 2     
    20. Lopez DS, Polychronopoulou E, Tsilidis KK, Khera M, Su LJ, Fowke JH, Peek MK, Kuo YF, Markides K, Canfield S, Lopez DS, Polychronopoulou E, Tsilidis KK, Khera M, Su LJ, Fowke JH, Peek MK, Kuo YF, Markides K, Canfield S. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men. Cancer Prev Res (Phila). 2021 07; 14(7):719-728. PMID: 33879532; PMCID: PMC8260462.
      Citations: 2     Fields:    Translation:Humans
    21. Brimley S, Natale C, Dick B, Pastuszak A, Khera M, Baum N, Raheem OA, Brimley S, Natale C, Dick B, Pastuszak A, Khera M, Baum N, Raheem OA. The Emerging Critical Role of Telemedicine in the Urology Clinic: A Practical Guide. Sex Med Rev. 2021 04; 9(2):289-295. PMID: 33752994; PMCID: PMC9585225.
      Citations: 1     Fields:    Translation:Humans
    22. Auerbach JM, Khera M, Auerbach JM, Khera M. Testosterone's Role in COVID-19. J Sex Med. 2021 05; 18(5):843-848. PMID: 33903045; PMCID: PMC7972673.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    23. Koller C, Fustok J, Hua J, Triche B, Hellstrom W, Khera M, Raheem O, Koller C, Fustok J, Hua J, Triche B, Hellstrom W, Khera M, Raheem O. Unilateral Corporal Cavernosum Partial Thrombosis: A Challenging Presentation and Management. Urology. 2021 06; 152:12-14. PMID: 33600835.
      Citations:    Fields:    Translation:Humans
    24. Natale C, Carlos C, Hong J, Khera M, Baum N, Raheem OA, Natale C, Carlos C, Hong J, Khera M, Baum N, Raheem OA. Testosterone Therapy After Prostate Cancer Treatment: A Review of Literature. Sex Med Rev. 2021 07; 9(3):393-405. PMID: 33516741.
      Citations: 1     Fields:    Translation:Humans
    25. Khera M, Miner M, Jaffe J, Pastuszak AW, Khera M, Miner M, Jaffe J, Pastuszak AW. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk. J Sex Med. 2021 01; 18(1):83-98. PMID: 33317996.
      Citations: 3     Fields:    Translation:Humans
    26. Twitchell DK, Pastuszak AW, Khera M, Twitchell DK, Pastuszak AW, Khera M. Controversies in Testosterone Therapy. Sex Med Rev. 2021 01; 9(1):149-159. PMID: 33309270.
      Citations: 1     Fields:    Translation:Humans
    27. Khera M, Mulcahy J, Wen L, Wilson SK, Khera M, Mulcahy J, Wen L, Wilson SK. Is there still a place for malleable penile implants in the United States? Wilson's Workshop #18. Int J Impot Res. 2020 Dec 03. PMID: 33273715.
      Citations: 1     Fields:    
    28. Auerbach JM, Khera M, Auerbach JM, Khera M. Hypogonadism management and cardiovascular health. Postgrad Med. 2020 Dec; 132(sup4):35-41. PMID: 32799602.
      Citations: 2     Fields:    Translation:Humans
    29. Thirumavalavan N, Scovell JM, Lo E, Gondokusomo J, Khera M, Pastuszak AW, Lipshultz LI, Thirumavalavan N, Scovell JM, Lo E, Gondokusomo J, Khera M, Pastuszak AW, Lipshultz LI. Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study. Int J Impot Res. 2022 Jan; 34(1):50-54. PMID: 33028968.
      Citations:    Fields:    Translation:Humans
    30. Wittmann D, Khera M, Trost L, Mulhall J, Wittmann D, Khera M, Trost L, Mulhall J. Response to Commentary on Contemporary Considerations in a Man With Low Sex Drive. J Sex Med. 2020 11; 17(11):2311. PMID: 32952048.
      Citations:    Fields:    Translation:Humans
    31. Khera M, Khera M. Controversies with testosterone therapy. Can J Urol. 2020 08; 27(S3):20-23. PMID: 32875998.
      Citations: 1     Fields:    Translation:Humans
    32. Raheem OA, Natale C, Dick B, Reddy AG, Yousif A, Khera M, Baum N, Raheem OA, Natale C, Dick B, Reddy AG, Yousif A, Khera M, Baum N. Novel Treatments of Erectile Dysfunction: Review of the Current Literature. Sex Med Rev. 2021 01; 9(1):123-132. PMID: 32631812.
      Citations: 2     Fields:    Translation:HumansAnimals
    33. Khera M, Than JK, Anaissie J, Antar A, Song W, Losso B, Pastuszak A, Kohn T, Mirabal JR, Khera M, Than JK, Anaissie J, Antar A, Song W, Losso B, Pastuszak A, Kohn T, Mirabal JR. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia. Transl Androl Urol. 2020 Jun; 9(3):1201-1209. PMID: 32676403; PMCID: PMC7354335.
      Citations: 2     
    34. Wittmann D, Khera M, Trost L, Mulhall J, Wittmann D, Khera M, Trost L, Mulhall J. Contemporary Considerations in the Pathophysiology of Low Sex Drive in Men. J Sex Med. 2020 06; 17(6):1049-1052. PMID: 32115396.
      Citations:    Fields:    
    35. Lo EM, Balasubramanian A, Pastuszak AW, Khera M, Lo EM, Balasubramanian A, Pastuszak AW, Khera M. Bipolar Androgen Therapy in Prostate Cancer (Update). J Sex Med. 2020 05; 17(5):831-834. PMID: 32033864.
      Citations: 1     Fields:    
    36. Morgentaler A, Traish AM, Khera M, Morgentaler A, Traish AM, Khera M. A Critique of the AUA Guidelines on Testosterone Deficiency. J Sex Med. 2020 04; 17(4):561-564. PMID: 31812687.
      Citations:    Fields:    
    37. Lopez DS, Huang D, Tsilidis KK, Khera M, Williams SB, Urban RJ, Panagiotou OA, Kuo YF, Baillargeon J, Farias A, Krause T, Lopez DS, Huang D, Tsilidis KK, Khera M, Williams SB, Urban RJ, Panagiotou OA, Kuo YF, Baillargeon J, Farias A, Krause T. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database. Clin Endocrinol (Oxf). 2019 12; 91(6):885-891. PMID: 31498469; PMCID: PMC7294776.
      Citations: 4     Fields:    Translation:Humans
    38. Khera M, Sadeghi-Nejad H, Khera M, Sadeghi-Nejad H. Editorial Comment. J Urol. 2019 09; 202(3):610. PMID: 31199177.
      Citations:    Fields:    Translation:Humans
    39. Khera M, Bivalacqua T, Goldstein I, Albersen M, Khera M, Bivalacqua T, Goldstein I, Albersen M. An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress? Eur Urol Focus. 2019 Jul; 5(4):536-538. PMID: 31196678.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    40. Salonia A, Rastrelli G, Hackett G, Seminara SB, Huhtaniemi IT, Rey RA, Hellstrom WJG, Palmert MR, Corona G, Dohle GR, Khera M, Chan YM, Maggi M, Salonia A, Rastrelli G, Hackett G, Seminara SB, Huhtaniemi IT, Rey RA, Hellstrom WJG, Palmert MR, Corona G, Dohle GR, Khera M, Chan YM, Maggi M. Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers. 2019 May 30; 5(1):38. PMID: 31147553; PMCID: PMC6944317.
      Citations: 41     Fields:    Translation:Humans
    41. Bates JN, Pastuszak AW, Khera M, Bates JN, Pastuszak AW, Khera M. Effect of Body Weight on Sexual Function in Men and Women. Curr Sex Health Rep. 2019 Mar; 11(1):52-59. PMID: 31576197; PMCID: PMC6771291.
      Citations: 1     
    42. Scovell JM, Khera M, Scovell JM, Khera M. Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male. Eur Urol Focus. 2018 04; 4(3):321-323. PMID: 30131284.
      Citations: 2     Fields:    Translation:Humans
    43. Rodriguez KM, Pastuszak AW, Khera M, Rodriguez KM, Pastuszak AW, Khera M. The Role of Testosterone Therapy in the Setting of Prostate Cancer. Curr Urol Rep. 2018 Jun 30; 19(8):67. PMID: 29961247.
      Citations: 7     Fields:    Translation:Humans
    44. Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW, Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW. Erectile Dysfunction: AUA Guideline. J Urol. 2018 09; 200(3):633-641. PMID: 29746858.
      Citations: 116     Fields:    Translation:Humans
    45. Lopez DS, Advani S, Qiu X, Tsilidis KK, Khera M, Kim J, Canfield S, Lopez DS, Advani S, Qiu X, Tsilidis KK, Khera M, Kim J, Canfield S. Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012. Aging Male. 2019 Mar; 22(1):45-54. PMID: 29692226.
      Citations: 1     Fields:    Translation:Humans
    46. Miner M, Morgentaler A, Khera M, Traish AM, Miner M, Morgentaler A, Khera M, Traish AM. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. Clin Endocrinol (Oxf). 2018 07; 89(1):3-10. PMID: 29486065.
      Citations: 1     Fields:    Translation:Humans
    47. Khera M, Bella A, Karpman E, Brant W, Christine B, Kansas B, Jones L, Kohler T, Bennett N, Rhee E, Henry G, Khera M, Bella A, Karpman E, Brant W, Christine B, Kansas B, Jones L, Kohler T, Bennett N, Rhee E, Henry G. Penile Prosthesis Implantation in Patients With Peyronie's Disease: Results of the PROPPER Study Demonstrates a Decrease in Patient-Reported Depression. J Sex Med. 2018 05; 15(5):786-788. PMID: 29653913.
      Citations: 9     Fields:    Translation:Humans
    48. Grabner M, Hepp Z, Raval A, Tian F, Khera M, Grabner M, Hepp Z, Raval A, Tian F, Khera M. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. J Sex Med. 2018 02; 15(2):148-158. PMID: 29425664.
      Citations: 1     Fields:    Translation:Humans
    49. Sigalos JT, Pastuszak AW, Khera M, Sigalos JT, Pastuszak AW, Khera M. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes. Med Clin North Am. 2018 Mar; 102(2):361-372. PMID: 29406064.
      Citations: 4     Fields:    Translation:Humans
    50. Bennett N, Henry G, Karpman E, Brant W, Jones L, Khera M, Kohler T, Christine B, Rhee E, Kansas B, Bella AJ, Bennett N, Henry G, Karpman E, Brant W, Jones L, Khera M, Kohler T, Christine B, Rhee E, Kansas B, Bella AJ. Inflatable penile prosthesis implant length with baseline characteristic correlations: preliminary analysis of the PROPPER study. Transl Androl Urol. 2017 Dec; 6(6):1167-1174. PMID: 29354506; PMCID: PMC5760375.
      Citations: 3     
    51. Lo EM, Rodriguez KM, Pastuszak AW, Khera M, Lo EM, Rodriguez KM, Pastuszak AW, Khera M. Alternatives to Testosterone Therapy: A Review. Sex Med Rev. 2018 01; 6(1):106-113. PMID: 29174957.
      Citations: 19     Fields:    Translation:Humans
    52. Rizk PJ, Kohn TP, Pastuszak AW, Khera M, Rizk PJ, Kohn TP, Pastuszak AW, Khera M. Testosterone therapy improves erectile function and libido in hypogonadal men. Curr Opin Urol. 2017 Nov; 27(6):511-515. PMID: 28816715; PMCID: PMC5649360.
      Citations: 7     Fields:    Translation:Humans
    53. Song W, Soni V, Soni S, Khera M, Song W, Soni V, Soni S, Khera M. Testosterone inhibits the growth of prostate cancer xenografts in nude mice. BMC Cancer. 2017 Sep 07; 17(1):635. PMID: 28877700; PMCID: PMC5588749.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    54. Mobley DF, Khera M, Baum N, Mobley DF, Khera M, Baum N. Recent advances in the treatment of erectile dysfunction. Postgrad Med J. 2017 Nov; 93(1105):679-685. PMID: 28751439.
      Citations: 24     Fields:    Translation:Humans
    55. Yafi FA, Haney NM, Anaissie J, DeLay KJ, Trost L, Khera M, Hellstrom WJG, Yafi FA, Haney NM, Anaissie J, DeLay KJ, Trost L, Khera M, Hellstrom WJG. Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members. Urology. 2017 Aug; 106:87-95. PMID: 28479477.
      Citations: 3     Fields:    Translation:Humans
    56. Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M, Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M. Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):285-296. PMID: 28262099.
      Citations: 15     Fields:    Translation:Humans
    57. Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M, Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M. Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):297-315. PMID: 28262100.
      Citations: 21     Fields:    Translation:Humans
    58. Sanchez E, Pastuszak AW, Khera M, Sanchez E, Pastuszak AW, Khera M. Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies. Transl Androl Urol. 2017 Feb; 6(1):28-36. PMID: 28217448; PMCID: PMC5313297.
      Citations: 9     
    59. Grabner M, Bodhani A, Khandelwal N, Palli S, Bonine N, Khera M, Grabner M, Bodhani A, Khandelwal N, Palli S, Bonine N, Khera M. Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population. J Sex Med. 2017 01; 14(1):88-97. PMID: 27939338.
      Citations:    Fields:    Translation:Humans
    60. Pastuszak AW, Rodriguez KM, Nguyen TM, Khera M, Pastuszak AW, Rodriguez KM, Nguyen TM, Khera M. Testosterone therapy and prostate cancer. Transl Androl Urol. 2016 Dec; 5(6):909-920. PMID: 28078223; PMCID: PMC5182214.
      Citations: 8     
    61. Khera M, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Salonia A, Khera M, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Salonia A. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 12; 13(12):1787-1804. PMID: 27914560.
      Citations: 29     Fields:    Translation:Humans
    62. Podlasek CA, Mulhall J, Davies K, Wingard CJ, Hannan JL, Bivalacqua TJ, Musicki B, Khera M, González-Cadavid NF, Burnett AL, Podlasek CA, Mulhall J, Davies K, Wingard CJ, Hannan JL, Bivalacqua TJ, Musicki B, Khera M, González-Cadavid NF, Burnett AL. Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction. J Sex Med. 2016 08; 13(8):1183-98. PMID: 27436075; PMCID: PMC5333763.
      Citations: 12     Fields:    Translation:Humans
    63. Khera M, Khera M. Editorial Comment on "Couple-Based Psychosexual Support Following Prostate Cancer Surgery: Results of a Feasibility Pilot Randomized Control Trial". J Sex Med. 2016 08; 13(8):1243-4. PMID: 27436078.
      Citations:    Fields:    Translation:Humans
    64. Khera M, Broderick GA, Carson CC, Dobs AS, Faraday MM, Goldstein I, Hakim LS, Hellstrom WJ, Kacker R, Köhler TS, Mills JN, Miner M, Sadeghi-Nejad H, Seftel AD, Sharlip ID, Winters SJ, Burnett AL, Khera M, Broderick GA, Carson CC, Dobs AS, Faraday MM, Goldstein I, Hakim LS, Hellstrom WJ, Kacker R, Köhler TS, Mills JN, Miner M, Sadeghi-Nejad H, Seftel AD, Sharlip ID, Winters SJ, Burnett AL. Adult-Onset Hypogonadism. Mayo Clin Proc. 2016 07; 91(7):908-26. PMID: 27343020.
      Citations: 19     Fields:    Translation:Humans
    65. Hatzimouratidis K, Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, McCullough A, Torres LO, Khera M, Hatzimouratidis K, Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, McCullough A, Torres LO, Khera M. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 Apr; 13(4):465-88. PMID: 27045254.
      Citations: 49     Fields:    Translation:Humans
    66. Khera M, Khera M. Testosterone Therapies. Urol Clin North Am. 2016 May; 43(2):185-93. PMID: 27132575.
      Citations: 2     Fields:    Translation:Humans
    67. Khera M, Khera M. Male hormones and men's quality of life. Curr Opin Urol. 2016 Mar; 26(2):152-7. PMID: 26765046.
      Citations: 15     Fields:    Translation:Humans
    68. Khera M, Khera M. Testosterone is Protective against Cardiac Disease: Pro. J Urol. 2016 04; 195(4 Pt 1):831-2. PMID: 26807929.
      Citations:    Fields:    Translation:Humans
    69. Khera M, Khera M. Changing paradigm of men's health. Indian J Urol. 2016 Jan-Mar; 32(1):5. PMID: 26941487; PMCID: PMC4756550.
      Citations:    
    70. Dean J, Maggi M, de Boer BJ, Hellstrom W, Khera M, Kim ED, McCullough A, Wu F, Zitzmann M, Dean J, Maggi M, de Boer BJ, Hellstrom W, Khera M, Kim ED, McCullough A, Wu F, Zitzmann M. Diagnosing secondary hypogonadism: important consequences for fertility and reversibility. BJU Int. 2016 Apr; 117(4):552-4. PMID: 26360119.
      Citations:    Fields:    Translation:Humans
    71. Hakky T, Lentz A, Sadeghi-Nejad H, Khera M, Hakky T, Lentz A, Sadeghi-Nejad H, Khera M. The Evolution of the Inflatable Penile Prosthesis Reservoir and Surgical Placement. J Sex Med. 2015 Nov; 12 Suppl 7:464-7. PMID: 26565579.
      Citations: 5     Fields:    Translation:Humans
    72. Khera M, Khera M. Testosterone Replacement in Men with Treated and Untreated Prostate Cancer. Sex Med Rev. 2013 Oct; 1(3):143-149. PMID: 27784553.
      Citations: 2     Fields:    
    73. Khera M, Khera M. Testosterone Therapy for Female Sexual Dysfunction. Sex Med Rev. 2015 Jul; 3(3):137-144. PMID: 27784606.
      Citations: 4     Fields:    
    74. Song W, Soni V, Khera M, Song W, Soni V, Khera M. Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer. Asian J Androl. 2015 Sep-Oct; 17(5):807-10. PMID: 25761834; PMCID: PMC4577595.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    75. Henry GD, Karpman E, Brant W, Christine B, Kansas BT, Khera M, Jones L, Kohler T, Bennett N, Rhee E, Eisenhart E, Bella AJ, Henry GD, Karpman E, Brant W, Christine B, Kansas BT, Khera M, Jones L, Kohler T, Bennett N, Rhee E, Eisenhart E, Bella AJ. The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data. J Urol. 2016 Feb; 195(2):427-33. PMID: 26292043.
      Citations: 14     Fields:    Translation:Humans
    76. Pastuszak AW, Gomez LP, Scovell JM, Khera M, Lamb DJ, Lipshultz LI, Pastuszak AW, Gomez LP, Scovell JM, Khera M, Lamb DJ, Lipshultz LI. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen. Sex Med. 2015 Sep; 3(3):165-73. PMID: 26468380; PMCID: PMC4599554.
      Citations: 15     
    77. Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, Khera M, Kirkby E, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW, Burnett AL, Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, Khera M, Kirkby E, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW, Burnett AL, American Urological Association Education and Research, Inc.,. Peyronie's Disease: AUA Guideline. J Urol. 2015 Sep; 194(3):745-53. PMID: 26066402; PMCID: PMC5027990.
      Citations: 79     Fields:    Translation:Humans
    78. Pastuszak AW, Khanna A, Badhiwala N, Morgentaler A, Hult M, Conners WP, Sarosdy MF, Yang C, Carrion R, Lipshultz LI, Khera M, Pastuszak AW, Khanna A, Badhiwala N, Morgentaler A, Hult M, Conners WP, Sarosdy MF, Yang C, Carrion R, Lipshultz LI, Khera M. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194(5):1271-6. PMID: 26025500.
      Citations: 14     Fields:    Translation:Humans
    79. Khera M, Albersen M, Mulhall JP, Khera M, Albersen M, Mulhall JP. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015 May; 12(5):1105-6. PMID: 25974235.
      Citations: 6     Fields:    Translation:HumansCells
    80. Ferrati S, Nicolov E, Zabre E, Geninatti T, Shirkey BA, Hudson L, Hosali S, Crawley M, Khera M, Palapattu G, Grattoni A, Ferrati S, Nicolov E, Zabre E, Geninatti T, Shirkey BA, Hudson L, Hosali S, Crawley M, Khera M, Palapattu G, Grattoni A. The nanochannel delivery system for constant testosterone replacement therapy. J Sex Med. 2015 Jun; 12(6):1375-80. PMID: 25930087.
      Citations: 15     Fields:    Translation:Animals
    81. Pastuszak AW, Hyman DA, Yadav N, Godoy G, Lipshultz LI, Araujo AB, Khera M, Pastuszak AW, Hyman DA, Yadav N, Godoy G, Lipshultz LI, Araujo AB, Khera M. Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis. J Sex Med. 2015 Apr; 12(4):975-84. PMID: 25728904; PMCID: PMC4390459.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    82. Khera M, Khera M. Controversies in testosterone supplementation therapy. Asian J Androl. 2015 Mar-Apr; 17(2):175-6. PMID: 25652639; PMCID: PMC4650474.
      Citations: 7     Fields:    Translation:Humans
    83. Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM, Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015 Feb; 90(2):224-51. PMID: 25636998.
      Citations: 59     Fields:    Translation:Humans
    84. Traish AM, Morgentaler A, Khera M, Traish AM, Morgentaler A, Khera M. RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 2015 Jan; 156(1):L1-2. PMID: 25526553.
      Citations:    Fields:    Translation:Animals
    85. Song W, Khera M, Song W, Khera M. Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro. Asian J Androl. 2014 Nov-Dec; 16(6):864-8. PMID: 24923459; PMCID: PMC4236330.
      Citations: 17     Fields:    Translation:HumansCells
    86. Ferrati S, Nicolov E, Bansal S, Zabre E, Geninatti T, Ziemys A, Hudson L, Ferrari M, Goodall R, Khera M, Palapattu G, Grattoni A, Ferrati S, Nicolov E, Bansal S, Zabre E, Geninatti T, Ziemys A, Hudson L, Ferrari M, Goodall R, Khera M, Palapattu G, Grattoni A. Delivering enhanced testosterone replacement therapy through nanochannels. Adv Healthc Mater. 2015 Feb 18; 4(3):446-51. PMID: 25274059.
      Citations: 11     Fields:    Translation:Animals
    87. Goldstein AT, Belkin ZR, Krapf JM, Song W, Khera M, Jutrzonka SL, Kim NN, Burrows LJ, Goldstein I, Goldstein AT, Belkin ZR, Krapf JM, Song W, Khera M, Jutrzonka SL, Kim NN, Burrows LJ, Goldstein I. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014 Nov; 11(11):2764-71. PMID: 25187224.
      Citations: 14     Fields:    Translation:HumansCells
    88. Dupree JM, Langille GM, Khera M, Lipshultz LI, Dupree JM, Langille GM, Khera M, Lipshultz LI. The safety of testosterone supplementation therapy in prostate cancer. Nat Rev Urol. 2014 Sep; 11(9):526-30. PMID: 25069737.
      Citations: 6     Fields:    Translation:Humans
    89. Trost LW, Khera M, Trost LW, Khera M. Alternative treatment modalities for the hypogonadal patient. Curr Urol Rep. 2014 Jul; 15(7):417. PMID: 24817260.
      Citations: 2     Fields:    Translation:Humans
    90. Morgentaler A, Khera M, Maggi M, Zitzmann M, Morgentaler A, Khera M, Maggi M, Zitzmann M. Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014 Jul; 11(7):1636-45. PMID: 24797325.
      Citations: 16     Fields:    Translation:Humans
    91. Khera M, Morgentaler A, Khera M, Morgentaler A. Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23. Eur Urol. 2014 Aug; 66(2):e33. PMID: 24836155.
      Citations:    Fields:    Translation:Humans
    92. Kovac JR, Gomez L, Smith RP, Coward RM, Gonzales MA, Khera M, Lamb DJ, Lipshultz LI, Kovac JR, Gomez L, Smith RP, Coward RM, Gonzales MA, Khera M, Lamb DJ, Lipshultz LI. Measurement of endothelial dysfunction via peripheral arterial tonometry predicts vasculogenic erectile dysfunction. Int J Impot Res. 2014 Nov-Dec; 26(6):218-22. PMID: 24784889; PMCID: PMC4216643.
      Citations: 4     Fields:    Translation:Humans
    93. Carson CC, Khera M, Carson CC, Khera M. Controversies in the treatment of male hypogonadism. Urology. 2014 Apr; 83(4):957. PMID: 24680460.
      Citations:    Fields:    Translation:Humans
    94. Khera M, Khera M. Patients with testosterone deficit syndrome and depression. Arch Esp Urol. 2013 Sep; 66(7):729-36. PMID: 24047633.
      Citations: 10     Fields:    Translation:Humans
    95. Darouiche RO, Bella AJ, Boone TB, Brock G, Broderick GA, Burnett AL, Carrion R, Carson C, Christine B, Dhabuwala CB, Hakim LS, Henry G, Jones LA, Khera M, Montague DK, Nehra A, Darouiche RO, Bella AJ, Boone TB, Brock G, Broderick GA, Burnett AL, Carrion R, Carson C, Christine B, Dhabuwala CB, Hakim LS, Henry G, Jones LA, Khera M, Montague DK, Nehra A. North American consensus document on infection of penile prostheses. Urology. 2013 Oct; 82(4):937-42. PMID: 23958508.
      Citations: 24     Fields:    Translation:Humans
    96. Khera M, Crawford D, Morales A, Salonia A, Morgentaler A, Khera M, Crawford D, Morales A, Salonia A, Morgentaler A. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014 Jan; 65(1):115-23. PMID: 24011426.
      Citations: 49     Fields:    Translation:Humans
    97. Soni SD, Song W, West JL, Khera M, Soni SD, Song W, West JL, Khera M. Nitric oxide-releasing polymeric microspheres improve diabetes-related erectile dysfunction. J Sex Med. 2013 Aug; 10(8):1915-25. PMID: 23751157.
      Citations: 3     Fields:    Translation:Animals
    98. Karpman E, Sadeghi-Nejad H, Henry G, Khera M, Morey AF, Karpman E, Sadeghi-Nejad H, Henry G, Khera M, Morey AF. Current opinions on alternative reservoir placement for inflatable penile prosthesis among members of the Sexual Medicine Society of North America. J Sex Med. 2013 Aug; 10(8):2115-20. PMID: 23679798.
      Citations: 15     Fields:    Translation:Humans
    99. Pastuszak AW, Badhiwala N, Lipshultz LI, Khera M, Pastuszak AW, Badhiwala N, Lipshultz LI, Khera M. Depression is correlated with the psychological and physical aspects of sexual dysfunction in men. Int J Impot Res. 2013 Sep; 25(5):194-9. PMID: 23466661.
      Citations: 14     Fields:    Translation:Humans
    100. Miner MM, Bhattacharya RK, Blick G, Kushner H, Khera M, Miner MM, Bhattacharya RK, Blick G, Kushner H, Khera M. 12-month observation of testosterone replacement effectiveness in a general population of men. Postgrad Med. 2013 Mar; 125(2):8-18. PMID: 23816767.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    101. Blick G, Khera M, Bhattacharya RK, Kushner H, Miner MM, Blick G, Khera M, Bhattacharya RK, Kushner H, Miner MM. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry. Postgrad Med. 2013 Mar; 125(2):19-29. PMID: 23816768.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    102. Pastuszak AW, Pearlman AM, Lai WS, Godoy G, Sathyamoorthy K, Liu JS, Miles BJ, Lipshultz LI, Khera M, Pastuszak AW, Pearlman AM, Lai WS, Godoy G, Sathyamoorthy K, Liu JS, Miles BJ, Lipshultz LI, Khera M. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44. PMID: 23395803; PMCID: PMC4544840.
      Citations: 54     Fields:    Translation:Humans
    103. Kim ED, Crosnoe L, Bar-Chama N, Khera M, Lipshultz LI, Kim ED, Crosnoe L, Bar-Chama N, Khera M, Lipshultz LI. The treatment of hypogonadism in men of reproductive age. Fertil Steril. 2013 Mar 01; 99(3):718-24. PMID: 23219010.
      Citations: 16     Fields:    Translation:Humans
    104. Moskovic DJ, Araujo AB, Lipshultz LI, Khera M, Moskovic DJ, Araujo AB, Lipshultz LI, Khera M. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med. 2013 Feb; 10(2):562-9. PMID: 23035926.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    105. Khera M, Khera M. Testosterone replacement in normal and pathologic prostate. Horm Mol Biol Clin Investig. 2012 Oct; 11(3):347-53. PMID: 25436694.
      Citations:    Fields:    
    106. Pastuszak AW, Pearlman AM, Godoy G, Miles BJ, Lipshultz LI, Khera M, Pastuszak AW, Pearlman AM, Godoy G, Miles BJ, Lipshultz LI, Khera M. Testosterone replacement therapy in the setting of prostate cancer treated with radiation. Int J Impot Res. 2013 Jan; 25(1):24-8. PMID: 22971614.
      Citations: 31     Fields:    Translation:Humans
    107. Bhattacharya RK, Khera M, Blick G, Kushner H, Miner MM, Bhattacharya RK, Khera M, Blick G, Kushner H, Miner MM. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging. 2012; 7:321-30. PMID: 22956867; PMCID: PMC3430096.
      Citations: 9     Fields:    Translation:Humans
    108. Blick G, Khera M, Bhattacharya RK, Nguyen D, Kushner H, Miner MM, Blick G, Khera M, Bhattacharya RK, Nguyen D, Kushner H, Miner MM. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS). Pain Med. 2012 May; 13(5):688-98. PMID: 22536837.
      Citations: 7     Fields:    Translation:Humans
    109. Pastuszak AW, Mittakanti H, Liu JS, Gomez L, Lipshultz LI, Khera M, Pastuszak AW, Mittakanti H, Liu JS, Gomez L, Lipshultz LI, Khera M. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012 Sep-Oct; 33(5):927-37. PMID: 22403285.
      Citations: 14     Fields:    Translation:Humans
    110. McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA, McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion. J Sex Med. 2012 Feb; 9(2):594-601. PMID: 22240203.
      Citations: 14     Fields:    Translation:Humans
    111. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). Aging Male. 2012 Mar; 15(1):14-21. PMID: 22092151.
      Citations: 13     Fields:    Translation:Humans
    112. Bhattacharya RK, Khera M, Blick G, Kushner H, Nguyen D, Miner MM, Bhattacharya RK, Khera M, Blick G, Kushner H, Nguyen D, Miner MM. Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord. 2011 Nov 01; 11:18. PMID: 22044661; PMCID: PMC3217857.
      Citations: 23     Fields:    
    113. Moskovic DJ, Freundlich RE, Yazdani P, Lipshultz LI, Khera M, Moskovic DJ, Freundlich RE, Yazdani P, Lipshultz LI, Khera M. Subcutaneous implantable testosterone pellets overcome noncompliance in adolescents with Klinefelter syndrome. J Androl. 2012 Jul-Aug; 33(4):570-3. PMID: 21940986.
      Citations: 4     Fields:    Translation:Humans
    114. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011 Nov; 8(11):3204-13. PMID: 21834870.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    115. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. J Urol. 2011 Sep; 186(3):1005-11. PMID: 21788049.
      Citations: 25     Fields:    Translation:Humans
    116. Pastuszak AW, Liu JS, Vij A, Mohamed O, Sathyamoorthy K, Lipshultz LI, Khera M, Pastuszak AW, Liu JS, Vij A, Mohamed O, Sathyamoorthy K, Lipshultz LI, Khera M. IGF-1 levels are significantly correlated with patient-reported measures of sexual function. Int J Impot Res. 2011 Sep-Oct; 23(5):220-6. PMID: 21753778.
      Citations:    Fields:    Translation:Humans
    117. Khera M, Goldstein I, Khera M, Goldstein I. Erectile dysfunction. BMJ Clin Evid. 2011 Jun 29; 2011. PMID: 21711956; PMCID: PMC3217797.
      Citations: 3     Fields:    Translation:Humans
    118. Moskovic DJ, Miles BJ, Lipshultz LI, Khera M, Moskovic DJ, Miles BJ, Lipshultz LI, Khera M. Emerging concepts in erectile preservation following radical prostatectomy: a guide for clinicians. Int J Impot Res. 2011 Sep-Oct; 23(5):181-92. PMID: 21697860.
      Citations: 10     Fields:    Translation:Humans
    119. Gittens P, Moskovic DJ, Avila D, Chandrashekar A, Khera M, Lipshultz LI, Gittens P, Moskovic DJ, Avila D, Chandrashekar A, Khera M, Lipshultz LI. Favorable female sexual function is associated with patient satisfaction after inflatable penile prosthesis implantation. J Sex Med. 2011 Jul; 8(7):1996-2001. PMID: 21569210.
      Citations: 9     Fields:    Translation:Humans
    120. Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H, Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. Postgrad Med. 2011 May; 123(3):17-27. PMID: 21566412.
      Citations: 5     Fields:    Translation:Humans
    121. Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D, Khera M, Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D, Khera M. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011 Apr; 185(4):1256-60. PMID: 21334649.
      Citations: 40     Fields:    Translation:Humans
    122. Lin YH, Kim JJ, Stein NB, Khera M, Lin YH, Kim JJ, Stein NB, Khera M. Malignant priapism secondary to metastatic prostate cancer: a case report and review of literature. Rev Urol. 2011; 13(2):90-4. PMID: 21935340; PMCID: PMC3176556.
      Citations: 18     
    123. Moskovic DJ, Pastuszak AW, Lipshultz LI, Khera M, Moskovic DJ, Pastuszak AW, Lipshultz LI, Khera M. Revision of penile prosthesis surgery after use of penile traction therapy to increase erect penile length: case report and review of the literature. J Sex Med. 2011 Feb; 8(2):607-11. PMID: 21091884.
      Citations: 7     Fields:    Translation:Humans
    124. Khera M, Khera M. Androgen replacement therapy after prostate cancer treatment. Curr Urol Rep. 2010 Nov; 11(6):393-9. PMID: 20838944.
      Citations: 5     Fields:    Translation:Humans
    125. Moskovic DJ, Mohamed O, Sathyamoorthy K, Miles BJ, Link RE, Lipshultz LI, Khera M, Moskovic DJ, Mohamed O, Sathyamoorthy K, Miles BJ, Link RE, Lipshultz LI, Khera M. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med. 2010 Nov; 7(11):3659-65. PMID: 20819141.
      Citations: 11     Fields:    Translation:Humans
    126. Weedin JW, Khera M, Lipshultz LI, Weedin JW, Khera M, Lipshultz LI. Reply by authors. J Urol. 2010 Jun; 183(6):2315. PMID: 20400155.
      Citations:    Fields:    Translation:Humans
    127. Weedin JW, Khera M, Lipshultz LI, Weedin JW, Khera M, Lipshultz LI. Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol. 2010 Jun; 183(6):2309-15. PMID: 20400156.
      Citations: 38     Fields:    Translation:Humans
    128. Bechara CF, Weakley SM, Kougias P, Athamneh H, Duffy P, Khera M, Kobayashi K, Lin PH, Bechara CF, Weakley SM, Kougias P, Athamneh H, Duffy P, Khera M, Kobayashi K, Lin PH. Percutaneous treatment of varicocele with microcoil embolization: comparison of treatment outcome with laparoscopic varicocelectomy. Vascular. 2009 Nov-Dec; 17 Suppl 3:S129-36. PMID: 19919803.
      Citations: 13     Fields:    Translation:Humans
    129. Mohamed O, Freundlich RE, Dakik HK, Grober ED, Najari B, Lipshultz LI, Khera M, Mohamed O, Freundlich RE, Dakik HK, Grober ED, Najari B, Lipshultz LI, Khera M. The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. Int J Impot Res. 2010 Jan-Feb; 22(1):20-4. PMID: 19657348; PMCID: PMC2834355.
      Citations: 17     Fields:    Translation:Humans
    130. Khera M, Grober ED, Najari B, Colen JS, Mohamed O, Lamb DJ, Lipshultz LI, Khera M, Grober ED, Najari B, Colen JS, Mohamed O, Lamb DJ, Lipshultz LI. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr; 6(4):1165-1170. PMID: 19207277.
      Citations: 46     Fields:    Translation:Humans
    131. Khera M, Khera M. Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men. J Sex Med. 2009 Mar; 6 Suppl 3:234-8. PMID: 19207279.
      Citations: 10     Fields:    Translation:Humans
    132. Khera M, Lipshultz LI, Khera M, Lipshultz LI. Evolving approach to the varicocele. Urol Clin North Am. 2008 May; 35(2):183-9, viii. PMID: 18423239.
      Citations: 20     Fields:    Translation:Humans
    133. Khera M, Lipshultz LI, Khera M, Lipshultz LI. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am. 2007 Nov; 34(4):549-53, vi. PMID: 17983894.
      Citations: 8     Fields:    Translation:Humans
    134. Khera M, Boone TB, Salas N, Jett MF, Somogyi GT, Khera M, Boone TB, Salas N, Jett MF, Somogyi GT. The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. BJU Int. 2007 Feb; 99(2):442-6. PMID: 17313428.
      Citations: 3     Fields:    Translation:Animals
    135. Miles BJ, Khera M, Miles BJ, Khera M. Can preoperative behavioral training reduce postprostatectomy incontinence? Nat Clin Pract Urol. 2006 Jun; 3(6):302-3. PMID: 16763638.
      Citations: 1     Fields:    Translation:Humans
    136. Khera M, Somogyi GT, Salas NA, Kiss S, Boone TB, Smith CP, Khera M, Somogyi GT, Salas NA, Kiss S, Boone TB, Smith CP. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology. 2005 Jul; 66(1):208-12. PMID: 15992889.
      Citations: 20     Fields:    Translation:Animals
    137. Khera M, Somogyi GT, Kiss S, Boone TB, Smith CP, Khera M, Somogyi GT, Kiss S, Boone TB, Smith CP. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int. 2004 Dec; 45(7):987-93. PMID: 15337297.
      Citations: 71     Fields:    Translation:Animals
    138. Khera M, Boone TB, Smith CP, Khera M, Boone TB, Smith CP. Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures. J Urol. 2004 Aug; 172(2):574-5. PMID: 15247734.
      Citations: 10     Fields:    Translation:Humans
    KHERA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (299)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _